UnitedHealth Group, CVS Health, and Cigna have filed lawsuits against several states, arguing that new legislation targeting their pharmacy businesses threatens to dismantle their integrated care models.

The suits center on regulations that seek to separate pharmacy operations from the broader health‑insurance and retail arms of these firms. By forcing a split, the laws could erode the economies of scale that allow the companies to negotiate lower drug prices and bundle services.

For the companies, a breakup would require costly restructuring and could weaken their competitive position in the pharmacy benefit manager market. It may also disrupt cross‑sell opportunities between health plans and pharmacy services that generate significant revenue.

Investors face increased regulatory risk and uncertainty about future earnings. Market participants must monitor court rulings in the coming months, as outcomes could reshape pricing dynamics and influence the valuation of all major pharmacy‑benefit players.